Skip to content

A prospective observational study about discontinuation or continuation of the antithrombotic drug at the time of the upper non-varix gastrointestinal tract bleeding

A prospective observational study about discontinuation or continuation of the antithrombotic drug at the time of the upper non-varix gastrointestinal tract bleeding - A prospective observational study about discontinuation or continuation of the antithrombotic drug at the time of the upper non-varix gastrointestinal tract bleeding

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000016381
Enrollment
150
Registered
2015-01-29
Start date
2015-01-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-varix upper gastrointestinal tract bleeding

Interventions

None listed

Sponsors

Gifu University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subjects obtained written informed consent 2) Subjects taking antithrombotic drug for more than 1 month 3) Subjects who had a diagnosis of upper gastrointestinal tract bleeding with esophagogastroduodenoscopy

Exclusion criteria

Exclusion criteria: bleeding from varix

Design outcomes

Primary

MeasureTime frame
Re-bleeding rate

Secondary

MeasureTime frame
number of times of hemostasis, fast period, length of stay, quantity of total blood transfusion

Countries

Japan

Contacts

Public ContactJun Takada

Gifu University Hospital Gastroenterology

jtakada-gifu@umin.ac.jp058-230-6308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026